Cargando…

Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study

BACKGROUND: Neglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD c...

Descripción completa

Detalles Bibliográficos
Autores principales: De Neve, Jan-Walter, Andriantavison, Rija L., Croke, Kevin, Krisam, Johannes, Rajoela, Voahirana H., Rakotoarivony, Rary A., Rambeloson, Valérie, Schultz, Linda, Qamruddin, Jumana, Verguet, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307713/
https://www.ncbi.nlm.nih.gov/pubmed/30589847
http://dx.doi.org/10.1371/journal.pntd.0007002
_version_ 1783383050939269120
author De Neve, Jan-Walter
Andriantavison, Rija L.
Croke, Kevin
Krisam, Johannes
Rajoela, Voahirana H.
Rakotoarivony, Rary A.
Rambeloson, Valérie
Schultz, Linda
Qamruddin, Jumana
Verguet, Stéphane
author_facet De Neve, Jan-Walter
Andriantavison, Rija L.
Croke, Kevin
Krisam, Johannes
Rajoela, Voahirana H.
Rakotoarivony, Rary A.
Rambeloson, Valérie
Schultz, Linda
Qamruddin, Jumana
Verguet, Stéphane
author_sort De Neve, Jan-Walter
collection PubMed
description BACKGROUND: Neglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD control. METHODS: We built on extended cost-effectiveness analysis (ECEA) methods to assess the health gains (e.g. infections, disability-adjusted life years or DALYs averted), household financial gains (out-of-pocket expenditures averted), and education gains (cases of school absenteeism averted) for five NTD interventions that the government of Madagascar aims to roll out nationally. The five NTDs considered were schistosomiasis, lymphatic filariasis, and three soil-transmitted helminthiases (Ascaris lumbricoides, Trichuris trichiura, and hookworm infections). RESULTS: The estimated incremental cost-effectiveness for the roll-out of preventive chemotherapy for all NTDs jointly was USD125 per DALY averted (95% uncertainty range: 65–231), and its benefit-cost ratio could vary between 5 and 31. Our analysis estimated that, per dollar spent, schistosomiasis preventive chemotherapy, in particular, could avert a large number of infections (176,000 infections averted per $100,000 spent), DALYs (2,000 averted per $100,000 spent), and cases of school absenteeism (27,000 school years gained per $100,000 spent). CONCLUSION: This analysis incorporates financial and education gains into the economic evaluation of health interventions, and therefore provides information about the efficiency of attainment of three Sustainable Development Goals (SDGs). Our findings reveal how the national scale-up of NTD control in Madagascar can help address health (SDG3), economic (SDG1), and education (SDG4) goals. This study further highlights the potentially large societal benefits of investing in NTD control in low-resource settings.
format Online
Article
Text
id pubmed-6307713
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-63077132019-01-08 Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study De Neve, Jan-Walter Andriantavison, Rija L. Croke, Kevin Krisam, Johannes Rajoela, Voahirana H. Rakotoarivony, Rary A. Rambeloson, Valérie Schultz, Linda Qamruddin, Jumana Verguet, Stéphane PLoS Negl Trop Dis Research Article BACKGROUND: Neglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD control. METHODS: We built on extended cost-effectiveness analysis (ECEA) methods to assess the health gains (e.g. infections, disability-adjusted life years or DALYs averted), household financial gains (out-of-pocket expenditures averted), and education gains (cases of school absenteeism averted) for five NTD interventions that the government of Madagascar aims to roll out nationally. The five NTDs considered were schistosomiasis, lymphatic filariasis, and three soil-transmitted helminthiases (Ascaris lumbricoides, Trichuris trichiura, and hookworm infections). RESULTS: The estimated incremental cost-effectiveness for the roll-out of preventive chemotherapy for all NTDs jointly was USD125 per DALY averted (95% uncertainty range: 65–231), and its benefit-cost ratio could vary between 5 and 31. Our analysis estimated that, per dollar spent, schistosomiasis preventive chemotherapy, in particular, could avert a large number of infections (176,000 infections averted per $100,000 spent), DALYs (2,000 averted per $100,000 spent), and cases of school absenteeism (27,000 school years gained per $100,000 spent). CONCLUSION: This analysis incorporates financial and education gains into the economic evaluation of health interventions, and therefore provides information about the efficiency of attainment of three Sustainable Development Goals (SDGs). Our findings reveal how the national scale-up of NTD control in Madagascar can help address health (SDG3), economic (SDG1), and education (SDG4) goals. This study further highlights the potentially large societal benefits of investing in NTD control in low-resource settings. Public Library of Science 2018-12-27 /pmc/articles/PMC6307713/ /pubmed/30589847 http://dx.doi.org/10.1371/journal.pntd.0007002 Text en © 2018 De Neve et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
De Neve, Jan-Walter
Andriantavison, Rija L.
Croke, Kevin
Krisam, Johannes
Rajoela, Voahirana H.
Rakotoarivony, Rary A.
Rambeloson, Valérie
Schultz, Linda
Qamruddin, Jumana
Verguet, Stéphane
Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
title Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
title_full Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
title_fullStr Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
title_full_unstemmed Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
title_short Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study
title_sort health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in madagascar: a modeling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307713/
https://www.ncbi.nlm.nih.gov/pubmed/30589847
http://dx.doi.org/10.1371/journal.pntd.0007002
work_keys_str_mv AT denevejanwalter healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT andriantavisonrijal healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT crokekevin healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT krisamjohannes healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT rajoelavoahiranah healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT rakotoarivonyrarya healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT rambelosonvalerie healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT schultzlinda healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT qamruddinjumana healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy
AT verguetstephane healthfinancialandeducationgainsofinvestinginpreventivechemotherapyforschistosomiasissoiltransmittedhelminthiasesandlymphaticfilariasisinmadagascaramodelingstudy